TY - JOUR
T1 - Cutting edge
T2 - Human FcRL4 and FcRL5 are receptors for IgA and IgG
AU - Wilson, Timothy J.
AU - Fuchs, Anja
AU - Colonna, Marco
PY - 2012/5/15
Y1 - 2012/5/15
N2 - Fc receptor-like (FcRL) proteins are a family of cellular receptors homologous to FcγRI and are predominantly expressed by B cells. They function to costimulate or inhibit BCR signaling through consensus ITAMs and ITIMs; however, the extracellular ligands of these receptors remain unknown or controversial. In this study, we tested the ability of human FcRL proteins to bind Igs and found FcRL4 and FcRL5 to be bona fide Fc receptors. In cellular binding assays, FcRL4 bound efficiently to IgA and FcRL5 binds all IgG isotypes with varied efficiency. Additionally, we generated mAbs capable of specifically blocking these interactions. Given their expression on activated B cells and potential for inhibitory signaling, FcRL4 and FcRL5 are likely to be important for immune complex-dependent human B cell regulation, and they represent novel therapeutic targets for receptor blockade therapies.
AB - Fc receptor-like (FcRL) proteins are a family of cellular receptors homologous to FcγRI and are predominantly expressed by B cells. They function to costimulate or inhibit BCR signaling through consensus ITAMs and ITIMs; however, the extracellular ligands of these receptors remain unknown or controversial. In this study, we tested the ability of human FcRL proteins to bind Igs and found FcRL4 and FcRL5 to be bona fide Fc receptors. In cellular binding assays, FcRL4 bound efficiently to IgA and FcRL5 binds all IgG isotypes with varied efficiency. Additionally, we generated mAbs capable of specifically blocking these interactions. Given their expression on activated B cells and potential for inhibitory signaling, FcRL4 and FcRL5 are likely to be important for immune complex-dependent human B cell regulation, and they represent novel therapeutic targets for receptor blockade therapies.
UR - http://www.scopus.com/inward/record.url?scp=84861130144&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1102651
DO - 10.4049/jimmunol.1102651
M3 - Article
C2 - 22491254
AN - SCOPUS:84861130144
SN - 0022-1767
VL - 188
SP - 4741
EP - 4745
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -